Animal models for the study of cancer-induced anorexia

S. Garattini, A. Guaitani

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Walker carcinoma 256/B transplanted sc in CD-COBS rats induce a decrease of food intake when the tumor size is less than 5% of the body weight. This anorexia is accompanied by a decrease of the adipose tissue and, to a lesser extent, of muscular tissue. The mechanism involved in cancer-induced anorexia seems to be different from that of classic centrally acting anorectic agents. Among the drugs tested to counteract this anorexia only cyproheptadine shows a modest effect. Cyclophosphamide reduces tumor growth and prevents decrease in food intake. It is suggested that Walker carcinoma 256/B may be a useful animal model to study problems related to cancer-induced anorexia and cachexia.

Original languageEnglish
Pages (from-to)23-35
Number of pages13
JournalCancer Treatment Reports
Volume65
Issue numberSuppl. 5
Publication statusPublished - 1981

Fingerprint

Anorexia
Animal Models
Walker Carcinoma 256
Neoplasms
Eating
Cyproheptadine
Appetite Depressants
Cachexia
Cyclophosphamide
Adipose Tissue
Body Weight
Growth
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Animal models for the study of cancer-induced anorexia. / Garattini, S.; Guaitani, A.

In: Cancer Treatment Reports, Vol. 65, No. Suppl. 5, 1981, p. 23-35.

Research output: Contribution to journalArticle

Garattini, S & Guaitani, A 1981, 'Animal models for the study of cancer-induced anorexia', Cancer Treatment Reports, vol. 65, no. Suppl. 5, pp. 23-35.
Garattini, S. ; Guaitani, A. / Animal models for the study of cancer-induced anorexia. In: Cancer Treatment Reports. 1981 ; Vol. 65, No. Suppl. 5. pp. 23-35.
@article{39c5ea6ffd804de2a20d99ed1372d7f4,
title = "Animal models for the study of cancer-induced anorexia",
abstract = "Walker carcinoma 256/B transplanted sc in CD-COBS rats induce a decrease of food intake when the tumor size is less than 5{\%} of the body weight. This anorexia is accompanied by a decrease of the adipose tissue and, to a lesser extent, of muscular tissue. The mechanism involved in cancer-induced anorexia seems to be different from that of classic centrally acting anorectic agents. Among the drugs tested to counteract this anorexia only cyproheptadine shows a modest effect. Cyclophosphamide reduces tumor growth and prevents decrease in food intake. It is suggested that Walker carcinoma 256/B may be a useful animal model to study problems related to cancer-induced anorexia and cachexia.",
author = "S. Garattini and A. Guaitani",
year = "1981",
language = "English",
volume = "65",
pages = "23--35",
journal = "Cancer Treatment Reports",
issn = "0361-5960",
publisher = "U.S. National Cancer Institute",
number = "Suppl. 5",

}

TY - JOUR

T1 - Animal models for the study of cancer-induced anorexia

AU - Garattini, S.

AU - Guaitani, A.

PY - 1981

Y1 - 1981

N2 - Walker carcinoma 256/B transplanted sc in CD-COBS rats induce a decrease of food intake when the tumor size is less than 5% of the body weight. This anorexia is accompanied by a decrease of the adipose tissue and, to a lesser extent, of muscular tissue. The mechanism involved in cancer-induced anorexia seems to be different from that of classic centrally acting anorectic agents. Among the drugs tested to counteract this anorexia only cyproheptadine shows a modest effect. Cyclophosphamide reduces tumor growth and prevents decrease in food intake. It is suggested that Walker carcinoma 256/B may be a useful animal model to study problems related to cancer-induced anorexia and cachexia.

AB - Walker carcinoma 256/B transplanted sc in CD-COBS rats induce a decrease of food intake when the tumor size is less than 5% of the body weight. This anorexia is accompanied by a decrease of the adipose tissue and, to a lesser extent, of muscular tissue. The mechanism involved in cancer-induced anorexia seems to be different from that of classic centrally acting anorectic agents. Among the drugs tested to counteract this anorexia only cyproheptadine shows a modest effect. Cyclophosphamide reduces tumor growth and prevents decrease in food intake. It is suggested that Walker carcinoma 256/B may be a useful animal model to study problems related to cancer-induced anorexia and cachexia.

UR - http://www.scopus.com/inward/record.url?scp=0019737488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019737488&partnerID=8YFLogxK

M3 - Article

C2 - 6955017

AN - SCOPUS:0019737488

VL - 65

SP - 23

EP - 35

JO - Cancer Treatment Reports

JF - Cancer Treatment Reports

SN - 0361-5960

IS - Suppl. 5

ER -